
ZBH Stock Forecast & Price Target
ZBH Analyst Ratings
Bulls say
Zimmer Biomet Holdings is a leading player in the orthopedic reconstructive implant market, with a strong presence across the US, Europe, and Japan through its recent acquisitions. While the company has divested its dental and spine businesses, its core focus on orthopedic implants positions it well to capture market share as demand for joint replacement surgeries continues to grow. The recent transition to a direct-sales model may cause some short-term disruption, but the company's strong fundamentals, including its robust product portfolio and continued investment in innovation, make it a solid long-term investment.
Bears say
Zimmer Biomet Holdings is facing headwinds in its core orthopedic arena due to pricing pressure and potential challenges with new product launches. Additionally, the company's significant exposure to international markets leaves it vulnerable to changes in market dynamics. While its acquisition of Paragon 28 has been a positive driver of growth, success in expanding its product portfolio will be crucial in driving sustainable growth and closing the valuation gap with peers.
This aggregate rating is based on analysts' research of Zimmer Biomet Hlds and is not a guaranteed prediction by Public.com or investment advice.
ZBH Analyst Forecast & Price Prediction
Start investing in ZBH
Order type
Buy in
Order amount
Est. shares
0 shares